Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Husband discusses wife’s improvement after treatment at the INR in Boca Raton, Florida, in December of 2017.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Tobinick E, Ignatowski, T., Spengler, R. On Overcoming Barriers to Application of Neuroinflammation Research. In: Abreu GEA, ed. Mechanisms of Neuroinflammation: InTechOpen; 2017.
Toni’s long-time personal assistant describes his rapid improvement after stroke treatment in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Family from Mumbai, India to the INR in 2015 & May 2017
Family from Mumbai, India on their second visit to the INR, in May 2017. First visit and treatment at the INR was in November 2015, four years after her stroke. The family discusses her neurological improvement after her first treatment at the INR. Her neurological improvement increased month after month and now has been sustained for 1 1/2 years and counting.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Patient traveled from Colorado to the INR in Boca Raton, Florida, in April 2017.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2017 INR PLLC, all rights reserved.
Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery (INR), invented the remarkable groundbreaking perispinal etanercept (PSE) treatment more than 25 years ago. As of July 2025, the INR has treated patients with chronic stroke from every state in the U.S. and from 109 countries.
PSE has been successfully used in the U.S., Europe and Australia to treat thousands of stroke survivors. In addition to unprecedented neurological improvements noted in thousands of patients and multiple published peer-reviewed scientific publications, the effectiveness of PSE for treating chronic stroke is also supported by favorable double-blind, randomized, placebo-controlled, university clinical trial data.
PSE is NOT a spinal injection. PSE involves a shallow, superficial injection with a very short, thin needle that CANNOT reach the spinal canal. Anesthesia is NOT NEEDED and patients can resume all of their usual activities immediately after treatment. Patients and their families have been amazed at how easy the process is.
The INR has treated patients from every populated continent of the world.
